OAK1 Antibody
-
中文名稱:OAK1 Antibody
-
貨號(hào):CSB-PA349763ZA01OAZ
-
規(guī)格:¥880
-
圖片:
-
其他:
產(chǎn)品詳情
-
產(chǎn)品名稱:Rabbit anti-Oldenlandia affinis OAK1 Polyclonal antibody
-
Uniprot No.:
-
基因名:OAK1
-
別名:Kalata-B1, OAK1
-
宿主:Rabbit
-
反應(yīng)種屬:Oldenlandia affinis
-
免疫原:Recombinant Oldenlandia affinisOAK1 protein (89-117aa )
-
免疫原種屬:Oldenlandia affinis
-
標(biāo)記方式:Non-conjugated
-
克隆類型:Polyclonal
-
抗體亞型:IgG
-
純化方式:Antigen Affinity Purified
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 -
產(chǎn)品提供形式:Liquid
-
應(yīng)用范圍:ELISA, WB
-
推薦稀釋比:
Application Recommended Dilution WB 1:500-1:5000 -
Protocols:
-
儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能:Probably participates in a plant defense mechanism. Has antibiotic activity. Has a diuretic effect. Has a uterotonic effect in humans. Active against the Gram-positive S.aureus with a minimum inhibition concentration of approximately 0.2 microM. Relatively ineffective against Gram-negative bacteria such as E.coli and P.aeruginosa. Inhibitory effect on the growth and development of larvae from H.punctigera. The unmodified form has hemolytic activity, the oxidized form lacks hemolytic activity. If the protein is linearized, hemolytic activity is lost.
-
蛋白家族:Cyclotide family, Moebius subfamily
-
組織特異性:Leaves and stems. Lower in roots.
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-













